RemeGen Biosciences

RemeGen Biosciences is a biopharmaceutical company, focusing on the discovery and development of innovative medicines for the treatment of cancer and autoimmune diseases, based in South San Francisco, California, and Rockville, Maryland. By leveraging our deep insights into oncology and immunology, advanced protein engineering/design technologies, and extensive knowledge in clinical development, our vision is to uncover the novel therapeutic targets and develop the best-in-class and first-in-class biotherapeutics for the patients with significant unmet medical needs. RemeGen Bioscience is a wholly owned subsidiary of RemeGen Co., a global pharmaceutic company specialized in autoimmune, oncology and ophthalmic diseases

Remegen biosciences operates in the Biotechnology industry.

Remegen biosciences's revenue is 11m - 100m

Remegen biosciences has 11 - 50 employees.